1. Home
  2. LCTX vs BZUN Comparison

LCTX vs BZUN Comparison

Compare LCTX & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCTX
  • BZUN
  • Stock Information
  • Founded
  • LCTX 1990
  • BZUN 2007
  • Country
  • LCTX United States
  • BZUN China
  • Employees
  • LCTX N/A
  • BZUN N/A
  • Industry
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • BZUN Catalog/Specialty Distribution
  • Sector
  • LCTX Health Care
  • BZUN Consumer Discretionary
  • Exchange
  • LCTX Nasdaq
  • BZUN Nasdaq
  • Market Cap
  • LCTX 110.2M
  • BZUN 188.7M
  • IPO Year
  • LCTX N/A
  • BZUN N/A
  • Fundamental
  • Price
  • LCTX $0.55
  • BZUN $2.74
  • Analyst Decision
  • LCTX Strong Buy
  • BZUN Strong Buy
  • Analyst Count
  • LCTX 5
  • BZUN 3
  • Target Price
  • LCTX $4.80
  • BZUN $3.20
  • AVG Volume (30 Days)
  • LCTX 2.9M
  • BZUN 874.6K
  • Earning Date
  • LCTX 03-06-2025
  • BZUN 11-21-2024
  • Dividend Yield
  • LCTX N/A
  • BZUN N/A
  • EPS Growth
  • LCTX N/A
  • BZUN N/A
  • EPS
  • LCTX N/A
  • BZUN N/A
  • Revenue
  • LCTX $8,719,000.00
  • BZUN $1,312,737,613.00
  • Revenue This Year
  • LCTX N/A
  • BZUN $8.16
  • Revenue Next Year
  • LCTX $41.15
  • BZUN $4.71
  • P/E Ratio
  • LCTX N/A
  • BZUN N/A
  • Revenue Growth
  • LCTX N/A
  • BZUN 7.26
  • 52 Week Low
  • LCTX $0.48
  • BZUN $1.90
  • 52 Week High
  • LCTX $1.61
  • BZUN $4.38
  • Technical
  • Relative Strength Index (RSI)
  • LCTX 47.26
  • BZUN 46.21
  • Support Level
  • LCTX $0.51
  • BZUN $2.67
  • Resistance Level
  • LCTX $0.60
  • BZUN $3.09
  • Average True Range (ATR)
  • LCTX 0.04
  • BZUN 0.17
  • MACD
  • LCTX 0.01
  • BZUN -0.03
  • Stochastic Oscillator
  • LCTX 53.85
  • BZUN 14.08

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

About BZUN Baozun Inc.

Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).

Share on Social Networks: